L090823 2023 Neurofibromatosis Symposium - Virtual Option
If you would like to attend the 2023 Neurofibromatosis Symposium VIRTUALLY, please register for this option. Once you select you option, we are not able to adjust or change to the in-person option.
Families, patients, physicians, nurses and genetic counselors.
- Summarize recent updates on nomenclature and diagnostic criteria for NF1 and NF2-related conditions
- Identify appropriate resources for management of spinal, ophthalmologic, and pregnancy complications in the neurofibromatosis
- Examine the impact of chronic diseases such as NF1 and NF2 on mental health and life experiences of those living with these conditions
2023 Neurofibromatosis Symposium Agenda
|7:30 - 8:00 a.m.||Registration|
|8:00 - 8:10 a.m.||Welcome and Introductions|
Dinel Pond, MS, CGC
|8:10 - 8:45 a.m.||Primary care for NF1||Marcelo Vargas, MD|
|8:45 - 9:15 a.m.||Patient Interview|
|9:15 - 10:00 a.m.||Eye Findings and Considerations in NF1||Catherine Origlieri, MD|
|10:00 - 10:15 a.m.||Break|
|10:15 - 11:00 a.m.||MEK Inhibitors||Vanina Taliercio, MD|
|11:00 - 11:50 a.m.||Spinal Complications in NF1||Tenner Guillaume, MD|
|11:50 - 12:45 p.m.||Lunch|
|12:45 - 1:30 p.m.||Chronic Disease and Mental Health||Krista Redlinger-Grosse, PhD, PLLC|
|1:30 - 2:15 p.m.||Neurofibromatosis: Perinatal considerations (this is a recorded presentation)||Myra Wick, MD, PhD|
|2:15 - 2:30 p.m.||Break|
|2:30 - 3:15 p.m.||NF2 Nomenclature||Radhika Dhamija, MBBS|
|3:15 - 4:00 p.m.||Pediatric NF2||Christopher Moertel, MD|
|4:00 - 4:30 p.m.||Research Updates|
|Amy Lebedoff, MD|
Dinel Pond, MS, CGC
Agenda subject to change.
It is our intent that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It is not assumed any potential conflicts will have an adverse impact on these presentations. It remains for the audience to determine whether the speaker’s outside interest may reflect a possible bias, either the exposition or the conclusions presented.
Planning committee members and presenter(s) have disclosed they have no relevant financial relationships with ineligible companies whose primary business is producing, marketing selling re-selling, or distributing healthcare products used by or on patients and have disclosed that no conflict of interest exists with the presentation/educational event.
Tenner Guillaume, MD, Orthopedic Surgery, Gillette Children’s
Christopher Moertel, MD, Hematology and Oncology, Masonic Children’s
Catherine Origlieri, MD, Ophthalmology, Northwest Eye
Krista Redlinger-Grosse, PhD PLLC, Licensed Psychologist and Genetic Counselor, Private Practice
Radhika Dhamija, MBBS, Neurologist, Medical Geneticist, Mayo Clinic
Vanina Taliercio, MD, Dermatology, Fellow in Medical Genetics and Genomics, University of Utah and Primary Children’s Hospital
Marcelo Vargas, MD, Genetics and Genomics, Children’s Minnesota
Myra Wick, MD PhD, Gynecologist and Medical Geneticist, Mayo Clinic
Amy Lebedoff, MD, Genetics and Genomics, Children’s Minnesota (Course Director)
Dinel Pond, MS CGC, Genetics and Genomics, Children’s Minnesota (Course Director)
Anne Bendel, MD, Pediatric Hematology and Oncology, Children's Minnesota
Brianna Depauw, RN, Hematology and Oncology, Children's Minnesota
Mary Skrypek, MD, Pediatric Hematology and Oncology, Children's Minnesota
Sara Wimmer, RN, Hematology and Oncology, Children's Minnesota
In support of improving patient care, Children’s Minnesota is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Children’s Minnesota takes responsibility for the content, quality and scientific interest of its accredited continuing education events.
Children’s Minnesota designates this enduring activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent to their participation in the activity.
Children's Minnesota designates this enduring activity for a maximum of 6.75 ANCC nursing contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This event has been submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and Contact Hours is currently pending.
This program offers 6.75 contact hours of continuing education. Most medical professional organizations accept AMA PRA Category 1 Credits™. It is the individual’s responsibility to determine whether an education activity meets the continuing education requirements of their respective licensures and/or professional boards. Go to your respective organization’s website for more detailed information regarding credit requirements.
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 6.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
- 6.75 AMA PRA Category 1 Credit™
- 6.75 ANCC
- 6.75 Attendance
- 6.75 Approved AMA PRA Category 1 Credit™
Please make sure to click the TAKE COURSE button to complete your registration for the event.
REGISTRATION CLOSES Wednesday, September 6 AT NOON.
WHEN SELECTING YOUR FORMAT OPTION, SELECT CAREFULLY AS NO TRANSFERS FROM ONE FORMAT TO THE OTHER WILL BE PERMITTED. YOU WILL BE LOCKED INTO YOUR VIEWING OPTION.
You will need a computer or phone with either internet or Wi-Fi access.